Etoposide, synthetic, 95.0-105.0%, powder
Etoposide, A cell-permeable derivative of podophyllotoxin that acts as a topoisomerase II inhibitor (IC₅₀ = 59.2 µM) has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma.
Etoposide, European Pharmacopoeia (EP) Reference Standard
Etoposide, British Pharmacopoeia (BP) Reference Standard
Etoposide, United States Pharmacopeia (USP) Reference Standard